Table 4.
Means and standard deviations of study outcome and process variables.
| ACT-SS (n = 21) | PCT (n = 19) | |||
|---|---|---|---|---|
| M | SD | M | SD | |
| Q-LES-Q-SF Total Score | ||||
| Baseline | 41.7 | 9.2 | 40.7 | 8.7 |
| End of Treatment | 44.0 | 10.0 | 39.1 | 11.1 |
| Three Month Follow-up | 44.1 | 8.7 | 39.2 | 11.9 |
| Q-LES-Q-SF Social Relationships | ||||
| Baseline | 2.00 | 1.10 | 2.47 | 1.02 |
| End of Treatment | 2.52 * | 1.21 | 2.26 | 1.10 |
| Three Month Follow-up | 2.57 * | 1.12 | 2.47 | 1.07 |
| MOS Social Support | ||||
| Baseline | 45.2 | 25.6 | 59.8 | 25.5 |
| End of Treatment | 45.8 | 23.9 | 59.8 | 29.6 |
| Three Month Follow-up | 49.4 | 27.4 | 62.2 | 27.0 |
| SAS-SR Social and Leisure Activities | ||||
| Baseline | 3.29 | 0.71 | 3.11 | 0.98 |
| End of Treatment | 2.90 * | 0.75 | 2.89 | 0.82 |
| Three Month Follow-up | 2.89 * | 0.74 | 3.13 | 0.92 |
| PTSD Symptom Checklist | ||||
| Baseline | 49.7 | 12.7 | 46.3 | 9.5 |
| End of Treatment | 40.9 * | 21.4 | 42.9 | 14.4 |
| Three Month Follow-up | 40.7 * | 18.2 | 43.5 | 16.2 |
| Mindfulness, Attention, and Awareness Scale | ||||
| Baseline | 3.01 | 0.86 | 3.50 | 0.80 |
| End of Treatment | 3.41 * | 0.94 | 3.31 | 1.10 |
| Three Month Follow-up | 3.24 | 0.79 | 3.40 | 1.17 |
| Acceptance and Action Questionnaire | ||||
| Baseline | 33.0 | 8.38 | 33.8 | 7.93 |
| End of Treatment | 28.9 * | 8.91 | 34.1 | 8.99 |
| Three Month Follow-up | 29.9 | 8.74 | 34.3 | 9.29 |
| Valued Living Questionnaire | ||||
| Baseline | 37.3 | 19.9 | 37.8 | 17.3 |
| End of Treatment | 45.7 * | 21.7 | 35.5 | 20.5 |
| Three Month Follow-up | 44.6 * | 22.3 | 32.1 | 18.0 |
Note. * p < 0.05. Q-LES-Q-SF = The Quality of Life Enjoyment and Satisfaction Questionnaire Short Form; MOS Social Support = The Medical Outcomes Study Social Support Survey; SAS-SR = Social Adjustment Scale-Self Report.